FDA
-
-
-
-
-
-
-
CVRx names interim head of sales amid leadership change
-
-
-
-
-
-
-
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
-
-
-
-
-
-
-
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
-
-
-
-
-
-
-
CVRX begins heart failure trial for expanded patient population
-
-
-
-
-
-
-
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
-
-
-
-
-
-
-
CMS proposes to maintain outpatient payment for CVRx Barostim procedure
-
-
-
-
-
-
-
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


